PROSTATAKREBSBEHANDLUNG
European patent · EP3518932 · In force
Register entry
- Publication number
- EP3518932
- Application number
- EP17823017
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Sep 29, 2017
- Published
- Aug 7, 2019
- Granted
- Nov 13, 2024
- Protection ends at the latest
- Sep 28, 2037
- Next annual fee due
- Sep 30, 2027
- IPC classes
- A61K 31/513 (2006.01)A61P 35/00 (2006.01)
- Priority
- US 201662402150 P 30.09.2016US 201662402004 P 30.09.2016
- PCT application
- PCT/EP2017/074849 29.09.2017
- PCT publication
- WO2018/060463 05.04.2018
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Oct 1, 2026
Next annual fee due on
- Next annual fee due on
- 30.09.2026 → 30.09.2027
Published in Swissreg on 01.10.2026
- Jun 4, 2026
Change
Published in Swissreg on 04.06.2026
- Oct 1, 2025
Next annual fee due on
- Next annual fee due on
- 30.09.2025 → 30.09.2026
Published in Swissreg on 01.10.2025
- Aug 20, 2025
Change
Published in Swissreg on 20.08.2025
- Aug 20, 2025
Change
Published in Swissreg on 20.08.2025
- Jan 15, 2025
Agent entered
- Representative
- Servopatent GmbH, Bühlstrasse 1, 8125 Zollikerberg
Published in Swissreg on 15.01.2025
- Nov 13, 2024
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 13.11.2024
Parties
Holder
Inventor
Apple Valley California, 92308, US
Chapel Hill North Carolina 27514, US
Middletown Rhode Island 02842, US
San Mateo California 94402, US
Cary North Carolina 27519, US
Cambridge, MA 02142, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.